S4E8: Dave Munichiello on Investing in AI’s Future
Throughout the fourth season of Theory and Practice, we explored emerging human-like artificial intelligence and robots. We asked if we coul...
Radio and PodcastLive Radio & Podcasts
Technology
Theory and Practice
Hosted by Anthony Philippakis (Venture Partner at GV) and Alex Wiltschko (Senior Research Scientist with Google AI), Theory and Practice opens the doors to the cutting edge of biology and co...
Episodes
20 of 36 episodesS4E7: Google DeepMind’s Clément Farabet on AI Reasoning
In this season of Theory and Practice, we explore newly emerging human-like artificial intelligence and robots — and how we can learn as muc...
S4E6: MIT’s James DiCarlo on Reverse-Engineering Human Sight with AI
Season 4 of our Theory and Practice podcast investigates the powerful new world of AI applications and what it means to be human in the age...
S4E5: Mapping the World of Smell to Broaden Diagnostics in Healthcare
On Season 4 of Theory and Practice, Anthony Philippakis and Alex Wiltschko explore newly emerging human-like artificial intelligence and rob...
S4E4: Moravec’s Paradox and the Evolution of Surgical Robotics
In Season 4 of the Theory and Practice podcast, we’ve been investigating the powerful new world of AI applications. We’ve explored how to bu...
S4E3: Computational Neuroscientist Dr. Thomas Reardon on Communication between Minds and Machines
On Season 4 of Theory and Practice, Anthony Philippakis and Alex Wiltschko explore newly emerging human-like artificial intelligence and rob...
S4E2: Google DeepMind’s Dr. Claire Cui on The Next Frontier for Large Language Models
On Season 4 of the Theory and Practice podcast, GV’s Anthony Philippakis and Osmo’s Alex Wiltschko explore being human in the age of AI. Gue...
S4E1: Being Human in the Age of AI: How to Responsibly Introduce AI into Healthcare
On Season 4 of the Theory and Practice podcast, hosts Anthony Philippakis and Alex Wiltschko explore the many aspects of what it means to be...
S3E7: Calico’s Cynthia Kenyon on The Science of Aging
For millennia, humans have believed that aging is inevitable. Yet thirty years ago, the work of Professor Cynthia Kenyon and her colleagues...
S3E6: Geoffrey Hinton on the Exploration of Thought
What is a thought? Some may think that question is quite abstract, but it has huge implications for science and computer design. If we canno...
S3E5: The Future of Psychiatry with Professor Karl Deisseroth
Psychiatry is changing and will be unrecognizable in the next 10-20 years, given our new understanding about the role of brain circuits in t...
S3E4: An Exploration of Protein Folding with Professor David Baker
Using machine learning to predict how a protein folds helps solve a riddle in biology. But it is just the start. These algorithms open up ne...
S3E3: The Future of Cancer Medicine with Dr. Jay Bradner, President of Novartis Institutes for BioMedical Research
In the last 20 years or so, many new cancer treatments have emerged that provide greater precision and targeting of cancer cells. Today, we...
S3E2: Breaking Barriers in Gene Editing with Harvard Professor David Liu
Gene editing is the process by which alterations are made to DNA. There are three major challenges: make precise edits at a chosen site, mak...
S3E1: The "Dark Genome" with Dr. Rosana Kapeller-Lieberman
For the third season of Theory and Practice , we wanted to ask: what lies ahead for the intersection of life sciences and data sciences in t...
S2E10: Bonus: The Patient's Perspective with Julia Vitarello
We first shared Julia's daughter's story a few weeks ago in our interview with Dr Timothy Yu about the first "N of 1" drug trial. Tim recoun...
S2E9: Genentech’s Aviv Regev on the Promise of Single Cell Genomics
It's rare to meet a true visionary, someone who sees where the world can go before anyone else sees it. And it's even rarer to meet someone...
S2E8: Dr. Amy Abernethy on Closing the Gap Between Clinical Practice and Clinical Research
Physicians make very big decisions in people's lives. Whether or not to put in a heart valve, whether to do a stent or surgery, what chemoth...
S2E7: Dr. David Altshuler on Translating the Human Genome Project Into Benefits for Human Health
David Altshuler is Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals. I first met David when...
S2E6: Dr. Tim Yu on Running the First “N of 1” Drug Trial
Every so often, someone comes up with a new idea that is truly visionary. The first time you see it, you may not immediately appreciate how...